Related Experiment Video
Updated: Jul 15, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis
Cesare Cuspidi1, Carla Sala2, Marijana Tadic3
1Department of Health Science, University of Milano-Bicocca, Milano, Italy; Istituto Auxologico Italiano, Milano, Italy; cesare.cuspidi@unimib.it.
Insights
Masked hypertension (MH), normal in-office but high out-of-office blood pressure, is linked to increased left ventricular structural alterations. Early screening for MH is crucial for detecting cardiac damage and guiding treatment to improve cardiovascular prognosis.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Background:
- Masked hypertension (MH) is defined by normal office blood pressure and elevated out-of-office readings.
- Subclinical cardiac damage associated with MH is not well-characterized.
- Ambulatory blood pressure monitoring is key to identifying MH.
Purpose of the Study:
- To conduct a meta-analysis assessing cardiac damage in individuals with masked hypertension.
- To provide comprehensive data on subclinical cardiac alterations in MH patients.
Main Methods:
- Systematic literature search for studies on masked hypertension and cardiac damage (left ventricular mass/hypertrophy).
- Inclusion of 12 studies analyzing data from 4,884 untreated subjects.
- Assessment of left ventricular mass index and hypertrophy prevalence using echocardiography.
Main Results:
- Left ventricular mass index progressively increased from normotensive to MH and sustained hypertensive groups.
- Significant differences in left ventricular mass index were observed between normotensive and MH individuals (P < 0.01).
- Publication bias was assessed, and the significant differences between groups persisted.
Conclusions:
- Masked hypertension is associated with a higher risk of left ventricular structural alterations compared to normotensive individuals.
- Subclinical cardiac damage in MH suggests a worse cardiovascular prognosis.
- Careful screening for MH is recommended to detect organ damage and initiate timely therapeutic interventions.
Aim:
Data on the association of masked hypertension (MH) (i.e., normal office and elevated out-of-office blood pressure (BP)) with cardiac damage are scanty. We performed a meta-analysis in order to provide a comprehensive information on subclinical cardiac alterations in subjects with MH.
Design:
Studies were identified by the following search terms: "masked hypertension," "white coat normotension," "isolated ambulatory hypertension," "left ventricular mass," "left ventricular hypertrophy," "cardiac damage," and "echocardiography." Full articles published in English language providing data on left ventricular (LV) mass and/or prevalence of LV hypertrophy in MH, as assessed by ambulatory BP monitoring, were considered.
Results:
Overall, 4,884 untreated subjects (2,467 normotensive, 776 MH, and 1,641 sustained hypertensive individuals) of both genders included in 12 studies were analyzed. LV mass index showed a progressive increase from normotensive (79.2 ± 0.35 g/m(2)) to MH (91.6 ± 4.0 g/m(2)) (standard difference in means (SDM): 0.50 ± 0.11, confidence interval (CI): 0.28-0.73, P < 0.01) and to hypertensive subjects (102.9 ± 3.3g/m(2)) (SDM: 0.22 ± 0.07, CI: 0.09-0.35, P < 0.01). After assessing data for publication bias, the difference between groups was still significant.
Conclusions:
Our findings support an association between MH and increased risk of LV structural alterations compared to true normotensive individuals. Due to the worse cardiovascular prognosis associated with subclinical cardiac damage, subjects with MH should be carefully screened in order to detect hypertensive organ damage and provide appropriate therapeutic interventions.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management

